AICAV
LIVE

Serial Number

97462526

Owner

CareDx Transplant Managment, Inc.

Attorney

Theresa Conduah

Filing Date

Jun 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AICAV Trademark

Serial Number: 97462526

AICAV is a trademark filed by CareDx Transplant Managment, Inc. on June 16, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

CareDx Transplant Managment, Inc. (5 trademarks)

10202 F Street
Omaha, NE 68127

Entity Type: 03

Trademark Details

Filing Date

June 16, 2022

Registration Date

Not Registered

Published for Opposition

September 19, 2023

Goods & Services

Providing online, non-downloadable software for use in informing clinical patient management in the medical and health care fields; Providing online, non-downloadable software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Providing online, non-downloadable software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Providing online, non-downloadable software for use with an electronic medical record system; Providing online, non-downloadable software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Providing online, non-downloadable software that include algorithms for use in the medical and healthcare fields; Providing online, non-downloadable software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Providing online, non-downloadable software that conducts predictive and risk analytics for use in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software for use in informing clinical patient management in the medical and health care fields; Providing temporary use of non-downloadable cloud based software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Providing temporary use of non-downloadable cloud based software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Providing temporary use of non-downloadable cloud based software for use with an electronic medical record system; Providing temporary use of non-downloadable cloud based software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Providing temporary use of non-downloadable cloud based software that include algorithms for use in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Providing temporary use of non-downloadable cloud based software that conducts predictive and risk analytics for use in the medical and healthcare fields; Software as a service (SaaS) services featuring software for use in informing clinical patient management in the medical and health care fields; Software as a service (SaaS) services featuring software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Software as a service (SaaS) services featuring software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Software as a service (SaaS) services featuring software for use with an electronic medical record system; Software as a service (SaaS) services featuring software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Software as a service (SaaS) services featuring software that include algorithms for use in the medical and healthcare fields; Software as a service (SaaS) services featuring software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Software as a service (SaaS) services featuring software that conducts predictive and risk analytics for use in the medical and healthcare fields

Downloadable software for use in informing clinical patient management in the medical and health care fields; Downloadable software for use in monitoring and analyzing patient healthcare information, allograft health and medical risk profile; Downloadable software for use in predictive analytics, health assessment, allograft assessment, medical risk assessment and medical risk probabilities; Downloadable software for use with an electronic medical record system; Downloadable software that enable users to input, view, track, aggregate, analyze, monitor and manage patient healthcare information and data for patient medical assessments; Downloadable software that include algorithms for use in the medical and healthcare fields; Downloadable software that include algorithms using molecular biomarkers for predictive analytics in the medical and healthcare fields; Downloadable software that conducts predictive and risk analytics for use in the medical and healthcare fields

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2026 EXRA
SOU EXTENSION 5 GRANTED
May 6, 2026 EX5G
SOU TEAS EXTENSION RECEIVED
May 5, 2026 EEXT
SOU EXTENSION 5 FILED
May 4, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 12, 2025 EX4G
SOU EXTENSION 4 FILED
Nov 12, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2025 EXRA
SOU EXTENSION 3 GRANTED
May 13, 2025 EX3G
SOU EXTENSION 3 FILED
May 13, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
May 13, 2025 EEXT
TEAS POST PUBLICATION AMENDMENT RECEIVED
Mar 4, 2025 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 23, 2024 EXRA
SOU EXTENSION 2 GRANTED
Dec 23, 2024 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 20, 2024 AITU
SOU EXTENSION 2 FILED
Nov 12, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 9, 2024 EX1G
SOU EXTENSION 1 FILED
May 9, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 9, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 14, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 4, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 4, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 4, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 4, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2022 NWOS
NEW APPLICATION ENTERED
Jun 20, 2022 NWAP